Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Phosphorylation/Dephosphorylation<br />
Glycogen Synthase Kinase <strong>Inhibitor</strong>s, continued<br />
Product Cat. No. Comments Size Price<br />
Cdk /5 <strong>Inhibitor</strong> 217720 (3-Amino-1H-pyrazolo[3,4-b]quinoxaline)<br />
A pyrazoloquinoxaline compound that effectively inhibits Cdk /B, Cdk 5/p25, and<br />
GSK-3b (IC 50 = 0.6 mM, 0.4 mM, and mM respectively).<br />
GSK-3b <strong>Inhibitor</strong> I 361540 (TDZD-8; 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione)<br />
A thiadiazolidinone (TDZD) analog that acts as a highly selective, non-ATP competitive<br />
inhibitor of GSK-3b (IC 50 = 2 mM). Proposed to bind to the active site of GSK-3b.<br />
GSK-3b <strong>Inhibitor</strong> II 361541 {Glycogen Synthase Kinase-3b <strong>Inhibitor</strong> II; 2-Thio(3-iodobenzyl)-5-(1-pyridyl)-<br />
[1,3,4]-oxadiazole}<br />
A 2-thio-[ ,3,4]-oxadiazole-pyridyl derivative that acts as a potent inhibitor of GSK-3b<br />
(IC 50 = 390 nM).<br />
GSK-3b <strong>Inhibitor</strong> III 361542 (2,4-Dibenzyl-5-oxothiadiazolidine-3-thione; OTDZT)<br />
An oxothiadiazolidine-3-thione analog that acts as a non-ATP competitive inhibitor of<br />
GSK-3b (IC 50 = 0 mM).<br />
N GSK-3b <strong>Inhibitor</strong> VI 361547 [2-Chloro-1-(4,5-dibromo-thiophen-2-yl)-ethanone]<br />
A thienyl a-chloromethyl ketone compound that acts as a cell-permeable, irreversible,<br />
and non-ATP competitive inhibitor of GSK-3b (IC 50 = mM). This reactive alkylating<br />
agent is selective towards GSK-3b and does not affect PKA activity even at<br />
concentrations as high as 00 mM.<br />
GSK-3b <strong>Inhibitor</strong> VII 361548 (a-4-Dibromoacetophenone; Tau Protein Kinase I <strong>Inhibitor</strong>; TPK I <strong>Inhibitor</strong>)<br />
A cell-permeable, selective, irreversible, and non-ATP competitive inhibitor of GSK-3b<br />
(IC 50 = 500 nM).<br />
GSK-3b <strong>Inhibitor</strong> VIII 361549 [AR-A014418; N-(4-Methoxybenzyl)-N´-(5-nitro-1,3-thiazol-2-yl)urea]<br />
A cell-permeable, potent, and highly specific inhibitor of glycogen synthase kinase-3b<br />
(GSK-3b) (IC 50 = 04 nM). Inhibition is competitive with respect to ATP (K i = 38 nM).<br />
N InSolution GSK-3b<br />
<strong>Inhibitor</strong> VIII<br />
5 mg $ 8<br />
5 mg $83<br />
5 mg $89<br />
mg $62<br />
5 mg $95<br />
5 mg $84<br />
5 mg $84<br />
361557 A 25 mM (5 mg/649 ml) solution of GSK-3b <strong>Inhibitor</strong> VIII (Cat. No. 36 549) in DMSO. 5 mg $84<br />
GSK-3 <strong>Inhibitor</strong> IX 361550 [BIO; (2´Z,3´E)-6-Bromoindirubin-3´-oxime]<br />
A cell-permeable, highly potent, selective, reversible, and ATP-competitive<br />
inhibitor of GSK-3a/b (IC 50 = 5 nM). At higher concentrations, inhibits Cdk2/cyclin A<br />
(IC 50 = 300 nM) and Cdk5/p25 (IC 50 = 83 nM).<br />
N InSolution GSK-3<br />
<strong>Inhibitor</strong> IX<br />
mg $95<br />
361552 A 0 mM (500 mg/ 40 ml) solution of GSK-3 <strong>Inhibitor</strong> IX (Cat. No. 36 550) in DMSO. 500 mg $63<br />
N GSK-3 <strong>Inhibitor</strong> X 361551 [BIO-Acetoxime; (2´Z,3´E)-6-Bromoindirubin-3´-acetoxime]<br />
An acetoxime analog of BIO (GSK-3 <strong>Inhibitor</strong> IX, Cat. No. 36 550) that exhibits greater<br />
selectivity for GSK-3a/b (IC 50 = 0 nM) over Cdk5/p25, Cdk2/A, and Cdk /B<br />
(IC 50 = 2.4 mM, 4.3 mM, and 63 mM, respectively).<br />
N GSK-3b <strong>Inhibitor</strong> XI 361553 {3-(1-(3-Hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-pyrazin-2-yl-pyrrole-2,<br />
5-dione}<br />
N GSK-3b <strong>Inhibitor</strong> XII,<br />
TWS 9<br />
A cell-permeable azaindolylmaleimide compound that acts as a potent, specific, and<br />
ATP-competitive inhibitor of GSK-3b (K i = 25 nM) and minimally inhibits a panel of 79<br />
commonly studied protein kinases, including several PKC isozymes. Shown to increase<br />
intracellular glycogen synthase activity in HEK293 cells with an EC 50 of 32 nM and<br />
demonstrate metabolic stability in human liver microsomes (HLM; t /2 > 00 min).<br />
361554 (Neurogenesis Inducer, TWS119)<br />
A cell-permeable pyrrolopyrimidine compound that acts as a potent and selective<br />
inhibitor of GSK-3b (IC 50 = 30 nM). Binds to GSK-3b with high-affinity (K d = 26 nM)<br />
and increases the level of b-catenin, a downstream substrate of GSK-3b in the Wnt<br />
signaling pathway.<br />
N GSK-3 <strong>Inhibitor</strong> XIII 361555 [(5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine]<br />
An aminopyrazole compound that acts as a potent and ATP-binding site inhibitor<br />
of GSK-3 with a K i of 24 nM.<br />
N GSK-3 <strong>Inhibitor</strong> XIV,<br />
Control, MeBIO<br />
361556 (1-Methyl-BIO)<br />
A cell-permeable N-methylated analog of GSK-3 <strong>Inhibitor</strong> IX, BIO (Cat. No. 36 550)<br />
that serves as a relevant kinase inactive control (IC 50 > 92 mM for Cdk /B, and > 00 mM<br />
for Cdk5/p25 and GSK-3a/b).<br />
mg $95<br />
mg $ 32<br />
20 Orders Phone 800 854 34 7<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Fax 800 776 0999<br />
Web www.emdbiosciences.com/calbiochem<br />
mg<br />
5 mg<br />
mg<br />
5 mg<br />
$90<br />
$278<br />
$67<br />
$20<br />
mg $93